Analysts Set Avantor, Inc. (NYSE:AVTR) PT at $26.71

Shares of Avantor, Inc. (NYSE:AVTR) have been given a consensus recommendation of “Moderate Buy” by the sixteen research firms that are presently covering the company, Marketbeat Ratings reports. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating on the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $26.71.

AVTR has been the topic of a number of recent analyst reports. Raymond James lifted their price objective on shares of Avantor from $22.50 to $26.00 and gave the company an “outperform” rating in a research note on Friday, January 26th. Citigroup upped their price objective on Avantor from $24.00 to $30.00 and gave the stock a “buy” rating in a research report on Thursday, February 15th. Royal Bank of Canada lifted their target price on Avantor from $28.00 to $29.00 and gave the company an “outperform” rating in a research report on Thursday, February 15th. Robert W. Baird boosted their target price on Avantor from $25.00 to $26.00 and gave the stock an “outperform” rating in a research note on Thursday, February 15th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on shares of Avantor from $23.00 to $25.00 and gave the company a “hold” rating in a research note on Thursday, April 18th.

Insider Buying and Selling

In other Avantor news, EVP James Bramwell sold 6,203 shares of the business’s stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total value of $151,911.47. Following the transaction, the executive vice president now directly owns 101,143 shares in the company, valued at $2,476,992.07. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.30% of the stock is owned by insiders.

Institutional Trading of Avantor

Large investors have recently modified their holdings of the business. Vanguard Group Inc. raised its stake in Avantor by 0.3% in the third quarter. Vanguard Group Inc. now owns 65,457,140 shares of the company’s stock valued at $1,379,837,000 after purchasing an additional 211,189 shares in the last quarter. Boston Partners raised its position in shares of Avantor by 21.4% during the 3rd quarter. Boston Partners now owns 28,077,026 shares of the company’s stock valued at $588,362,000 after buying an additional 4,948,951 shares in the last quarter. Artemis Investment Management LLP lifted its holdings in shares of Avantor by 14.9% during the 1st quarter. Artemis Investment Management LLP now owns 9,120,083 shares of the company’s stock worth $233,109,000 after acquiring an additional 1,180,937 shares during the last quarter. Robeco Schweiz AG grew its position in Avantor by 8.1% in the third quarter. Robeco Schweiz AG now owns 8,154,000 shares of the company’s stock worth $171,886,000 after acquiring an additional 607,500 shares in the last quarter. Finally, Norges Bank purchased a new position in Avantor in the fourth quarter worth $156,455,000. Institutional investors own 95.08% of the company’s stock.

Avantor Stock Up 1.3 %

Shares of AVTR stock opened at $24.41 on Friday. Avantor has a 52-week low of $16.63 and a 52-week high of $26.16. The stock has a market cap of $16.55 billion, a price-to-earnings ratio of 50.84, a PEG ratio of 2.45 and a beta of 1.37. The firm’s 50-day moving average is $24.96 and its 200-day moving average is $22.51. The company has a debt-to-equity ratio of 1.00, a quick ratio of 1.05 and a current ratio of 1.61.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Wednesday, February 14th. The company reported $0.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.03. The company had revenue of $1.72 billion during the quarter, compared to analysts’ expectations of $1.70 billion. Avantor had a return on equity of 14.11% and a net margin of 4.61%. The business’s revenue was down 4.0% on a year-over-year basis. During the same period last year, the firm posted $0.32 earnings per share. Sell-side analysts predict that Avantor will post 1.01 EPS for the current year.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.